Jeff Zucker Says Hypertrophic Cardiomyopathy is a Curable Disease: A Patient's Perspective

https://doi.org/10.1016/j.amjcard.2022.01.033Get rights and content
Under a Creative Commons license
open access

LV outflow obstruction in patients with hypertrophic cardiomyopathy can cause marked limiting symptoms of heart failure, reversible with surgical septal myectomy. Here we provide a patient's perspective on heart failure in hypertrophic cardiomyopathy and personal experience undergoing the myectomy operation to correct his substantial disability.

Cited by (0)

On October 16 to 18, 2021, the 3-day 7th International Summit on Hypertrophic Cardiomyopathy was held virtually with almost 700 registrants and faculty from 40 countries and 42 states (Drs. Martin and Barry Maron, Directors). This meeting, the largest held specifically for hypertrophic cardiomyopathy, was an opportunity to engage on a wide variety of topics with insights relevant to hypertrophic cardiomyopathy provided by 47 lectures, debates, and comprehensive discussions from 36 distinguished and accomplished international speakers.